SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001535610-20-000019
Filing Date
2020-01-08
Accepted
2020-01-07 18:54:06
Documents
1

Document Format Files

Seq Description Document Type Size
1 SABBY 13G-A MBRX 1.07.20 mbrx0120.txt SC 13G/A 11695
  Complete submission text file 0001535610-20-000019.txt   13234
Mailing Address 10 MOUNTAINVIEW ROAD SUITE 205 UPPER SADDLE RIVER NJ 07458
Business Address 10 MOUNTAINVIEW ROAD SUITE 205 UPPER SADDLE RIVER NJ 07458 646-307-4527
SABBY MANAGEMENT, LLC (Filed by) CIK: 0001535610 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Subject) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89866 | Film No.: 20514257
SIC: 2834 Pharmaceutical Preparations